Lars Klemm
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Acute Lymphoblastic Leukemia research 20
-
- FOXO transcription factor regulation 3
- Cancer-related gene regulation 3
- Co-authors
- Markus Müschen (29 shared papers)Eugene Park (14 shared papers)Nora Heisterkamp (12 shared papers)Huimin Geng (11 shared papers)Yong‐Mi Kim (12 shared papers)John Groffen (5 shared papers)Hassan Jumaa (12 shared papers)Michael R. Lieber (6 shared papers)
- Journals
- Blood (24 papers)Nature Communications (1 paper)Cancer Prevention Research (1 paper)The Journal of Experimental Medicine (1 paper)Nature Immunology (1 paper)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Lars Klemm
32 papers receiving 823 citations
Peers
Comparison fields: 5 of 63
- Hematology 208
- Genetics 104
- Public Health, Environmental and Occupational Health 242
- Immunology 177
- Oncology 172
Countries citing papers authored by Lars Klemm
This map shows the geographic impact of Lars Klemm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Klemm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Klemm more than expected).
Fields of papers citing papers by Lars Klemm
This network shows the impact of papers produced by Lars Klemm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Klemm. The network helps show where Lars Klemm may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Klemm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 134 | |
| 2 | 2015 | 127 | |
| 3 | 2009 | 121 | |
| 4 | 2009 | 92 | |
| 5 | 2018 | 92 | |
| 6 | 2011 | 90 | |
| 7 | 2015 | 41 | |
| 8 | 2010 | 40 | |
| 9 | 2012 | 21 | |
| 10 | 2012 | 12 | |
| 11 | 2013 | 12 | |
| 12 | 2009 | 8 | |
| 13 | 2010 | 5 | |
| 14 | 2015 | 4 | |
| 15 | 2013 | 4 | |
| 16 | 2009 | 3 | |
| 17 | 2010 | 3 | |
| 18 | 2016 | 2 | |
| 19 | 2009 | 2 | |
| 20 | 2017 | 2 |
About Lars Klemm
Lars Klemm is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology, Hematology, Immunology and Genetics, having authored 34 papers that have together received 828 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (20 papers), Chronic Myeloid Leukemia Treatments (10 papers), Chronic Lymphocytic Leukemia Research (9 papers), FOXO transcription factor regulation (3 papers), Cancer-related gene regulation (3 papers), Immune Cell Function and Interaction (3 papers), CAR-T cell therapy research (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Hematology (208 citations), Genetics (104 citations), Public Health, Environmental and Occupational Health (242 citations), Immunology (177 citations) and Oncology (172 citations). Lars Klemm has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Markus Müschen, Eugene Park, Nora Heisterkamp, Huimin Geng, Yong‐Mi Kim, John Groffen, Hassan Jumaa, Michael R. Lieber, Rafael Casellas and Srividya Swaminathan. Their work appears in journals such as Blood, Nature Communications, Cancer Prevention Research, The Journal of Experimental Medicine and Nature Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.